Search research articles
Contact Us
Filters
Showing results (91-100 of 251) with videos related to
Page
of 26
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 12, 2010
Toward optimized front-line therapeutic strategies in patients with metastatic colorectal cancer--an expert review from the International Congress on Anti-Cancer Treatment (ICACT) 2009
R Adam, D G Haller, G Poston, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 30, 2000
New directions in the treatment of colorectal cancer: a look to the future
A Sobrero, D Kerr, B Glimelius, et al.
Clinical Nuclear Medicine
|
October 1, 1990
Effect of proximal vagotomy and Roux-en-Y diversion on gastric emptying kinetics in asymptomatic patients
J L Urbain, F Penninckx, J A Siegel, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 27, 2002
Whole-body PET with FDG for the diagnosis of recurrent gastric cancer
T De Potter, P Flamen, E Van Cutsem, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland
|
May 23, 2013
Persisting anorectal dysfunction after rectal cancer surgery
A Maris, F Penninckx, A M Devreese, et al.
Nuklearmedizin. Nuclear Medicine
|
August 1, 1989
Effect of solid-meal caloric content on gastric emptying kinetics of solids and liquids
J L Urbain, J A Siegel, L Mortelmans, et al.
Familial Cancer
|
June 1, 2006
Germline mutations of the hMLH1 and hMSH2 mismatch repair genes in Belgian hereditary nonpolyposis colon cancer (HNPCC) patients
M Spaepen, B Vankeirsbilck, S Van Opstal, et al.
Liver
|
October 10, 1998
Primary liver tumour of intermediate (hepatocyte-bile duct cell) phenotype: a progenitor cell tumour?
C Robrechts, R De Vos, M Van den Heuvel, et al.
British Journal of Cancer
|
January 10, 2013
Cediranib with mFOLFOX6 vs bevacizumab with mFOLFOX6 in previously treated metastatic colorectal cancer
D Cunningham, R P W Wong, G D'Haens, et al.
ESMO Gastrointestinal Oncology
|
February 6, 2026
Managing adverse events in patients with metastatic colorectal cancer receiving trifluridine/tipiracil in combination with bevacizumab
M Fakih, F Ciardiello, G W Prager, et al.
Page
of 26
Search research articles
Search
Showing results (91-100 of 251) with videos related to
Sort By:
Page
of 26
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 12, 2010
Toward optimized front-line therapeutic strategies in patients with metastatic colorectal cancer--an expert review from the International Congress on Anti-Cancer Treatment (ICACT) 2009
R Adam, D G Haller, G Poston, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 30, 2000
New directions in the treatment of colorectal cancer: a look to the future
A Sobrero, D Kerr, B Glimelius, et al.
Clinical Nuclear Medicine
|
October 1, 1990
Effect of proximal vagotomy and Roux-en-Y diversion on gastric emptying kinetics in asymptomatic patients
J L Urbain, F Penninckx, J A Siegel, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 27, 2002
Whole-body PET with FDG for the diagnosis of recurrent gastric cancer
T De Potter, P Flamen, E Van Cutsem, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland
|
May 23, 2013
Persisting anorectal dysfunction after rectal cancer surgery
A Maris, F Penninckx, A M Devreese, et al.
Nuklearmedizin. Nuclear Medicine
|
August 1, 1989
Effect of solid-meal caloric content on gastric emptying kinetics of solids and liquids
J L Urbain, J A Siegel, L Mortelmans, et al.
Familial Cancer
|
June 1, 2006
Germline mutations of the hMLH1 and hMSH2 mismatch repair genes in Belgian hereditary nonpolyposis colon cancer (HNPCC) patients
M Spaepen, B Vankeirsbilck, S Van Opstal, et al.
Liver
|
October 10, 1998
Primary liver tumour of intermediate (hepatocyte-bile duct cell) phenotype: a progenitor cell tumour?
C Robrechts, R De Vos, M Van den Heuvel, et al.
British Journal of Cancer
|
January 10, 2013
Cediranib with mFOLFOX6 vs bevacizumab with mFOLFOX6 in previously treated metastatic colorectal cancer
D Cunningham, R P W Wong, G D'Haens, et al.
ESMO Gastrointestinal Oncology
|
February 6, 2026
Managing adverse events in patients with metastatic colorectal cancer receiving trifluridine/tipiracil in combination with bevacizumab
M Fakih, F Ciardiello, G W Prager, et al.
Page
of 26